Impact of Fiasp on Glycaemic Control in a Real World Population With Type 1 Diabetes Mellitus Using Flash Glucose Monitoring
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2019
Price : $35 *
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GoBolus
- Sponsors Novo Nordisk
- 14 Oct 2019 Status changed from active, no longer recruiting to completed.
- 15 May 2019 Status changed from recruiting to active, no longer recruiting.
- 14 Feb 2019 Planned number of patients changed from 686 to 440.